Dendritic cell derived cytokines in human natural killer cell differentiation and activation

Frontiers in Immunology

Volumn 4, Issue NOV, 2013, Pages

  Chijioke, Obinna ^a   Münz, Christian ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

DNAM 1; IFN alpha; IL 12; IL 15; IL 18; Immunological synapse; NKp30

Indexed keywords

EID: 84890422383     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00365     Document Type: Review

References (91)

1. Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer (1975) 16:216-29.
2. Kiessling R, Klein E, Wigzell H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol (1975) 5:112-7. doi: 10.1002/eji.1830050208
3. Trinchieri G, Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med (1978) 147:1314-33. doi:10.1084/jem.147.5.1299
4. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol (2002) 2:957-64. doi:10.1038/nri956
5. Barreira da Silva R, Münz C. Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals. Cell Mol Life Sci (2011) 68:3505-18. doi:10.1007/s00018-011-0801-8
6. Chijioke O, Münz C. Interactions of human myeloid cells with natural killer cell subsets in vitro and in vivo. J Biomed Biotechnol (2011) 2011:251679. doi:10.1155/2011/251679
7. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med (1999) 5:405-11. doi:10.1038/7403
8. Spörri R, Joller N, Hilbi H, Oxenius A. A novel role for neutrophils as critical activators of NK cells. J Immunol (2008) 181:7121-30.
9. Bihl F, Pecheur J, Breart B, Poupon G, Cazareth J, Julia V, et al. Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection. J Immunol (2010) 185:2174-81. doi:10.4049/jimmunol.1001486
10. + T cell-dependent activation of NK cells following vaccination. J Immunol (2010) 185:2808-18. doi:10.4049/jimmunol.1000844
11. Horowitz A, Newman KC, Evans JH, Korbel DS, Davis DM, Riley EM. Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes. J Immunol (2010) 184:6043-52. doi:10.4049/jimmunol.1000106
12. Jaeger BN, Donadieu J, Cognet C, Bernat C, Ordonez-Rueda D, Barlogis V, et al. Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. J Exp Med (2012) 209:565-80. doi:10.1084/jem.20111908
13. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol (2013) 31:563-604. doi:10.1146/annurev-immunol-020711-074950
14. + nonlymphoid dendritic cells. Immunity (2012) 37:60-73. doi:10.1016/j.immuni.2012.04.012
15. Maraskovsky E, Daro E, Roux E, Teepe M, Maliszewski CR, Hoek J, et al. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood (2000) 96:878-84.
16. Schmid MA, Kingston D, Boddupalli S, Manz MG. Instructive cytokine signals in dendritic cell lineage commitment. Immunol Rev (2010) 234:32-44. doi:10.1111/j.0105-2896.2009.00877.x
17. Greter M, Lelios I, Pelczar P, Hoeffel G, Price J, Leboeuf M, et al. Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity (2012) 37:1050-60. doi:10.1016/j.immuni.2012.11.001
18. Wang Y, Szretter KJ, Vermi W, Gilfillan S, Rossini C, Cella M, et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol (2012) 13:753-60. doi:10.1038/ni.2360
19. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol (2004) 5:987-95. doi:10.1038/ni1112
20. + DCs are major producers of IFN-lambda in response to poly IC. J Exp Med (2010) 207:2703-17. doi:10.1084/jem.20092720
21. + dendritic cells produce prominent amounts of IFN-alpha after dsRNA recognition and can be targeted via DEC-205 in humanized mice. Blood (2013) 121:5034-44. doi:10.1182/blood-2012-12-473413
22. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 31:227-58. doi:10.1146/annurev-immunol-020711-075005
23. Hoglund P, Brodin P. Current perspectives of natural killer cell education by MHC class I molecules. Nat Rev Immunol (2010) 10:724-34. doi:10.1038/nri2835
24. Parham P, Moffett A. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol (2013) 13:133-44. doi:10.1038/nri3370
25. Ferlazzo G, Thomas D, Lin SL, Goodman K, Morandi B, Muller WA, et al. The abundant NK cells in human lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol (2004) 172:1455-62.
26. dim NK cells upon activation. J Immunol (2007) 178:4947-55.
27. Freud AG, Yokohama A, Becknell B, Lee MT, Mao HC, Ferketich AK, et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med (2006) 203:1033-43. doi:10.1084/jem.20052507
28. dim NK-cell differentiation uncoupled from NK-cell education. Blood (2010) 116:3853-64. doi:10.1182/blood-2010-04-281675
29. De Maria A, Bozzano F, Cantoni C, Moretta L. Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN-gamma on activation. Proc Natl Acad Sci U S A (2011) 108:728-32. doi:10.1073/pnas.1012356108
30. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science (2011) 331:44-9. doi:10.1126/science.1198687
31. Beziat V, Liu LL, Malmberg JA, Ivarsson MA, Sohlberg E, Bjorklund AT, et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood (2013) 121:2678-88. doi:10.1182/blood-2012-10-459545
32. Paust S, von Andrian UH. Natural killer cell memory. Nat Immunol (2011) 12:500-8. doi:10.1038/ni.2032
33. Jost S, Altfeld M. Control of human viral infections by natural killer cells. Annu Rev Immunol (2013) 31:163-94. doi:10.1146/annurev-immunol-032712-100001
34. Paust S, Gill HS, Wang BZ, Flynn MP, Moseman EA, Senman B, et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol (2010) 11:1127-35. doi:10.1038/ni.1953
35. Shi FD, Ljunggren HG, La Cava A, Van Kaer L. Organ-specific features of natural killer cells. Nat Rev Immunol (2011) 11:658-71. doi:10.1038/nri3065
36. Fehniger TA, Cooper MA, Nuovo GJ, Cella M, Facchetti F, Colonna M, et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell derived IL-2: a potential new link between adaptive and innate immunity. Blood (2003) 102:3052-7. doi:10.1182/blood-2002-09-2876
37. Strowig T, Brilot F, Arrey F, Bougras G, Thomas D, Muller WA, et al. Tonsilar natural killer cells restrict B cell transformation by the Epstein Barr virus via IFN-γ. PLoS Pathog (2008) 4:e27. doi:10.1371/journal.ppat.0040027
38. Lünemann A, Vanoaica LD, Azzi T, Nadal D, Münz C. A distinct subpopulation of human natural killer cells restricts B cell transformation by EBV. J Immunol (published ahead of print October 9, 2013). doi:10.4049/jimmunol.1301046
39. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol (2002) 9:656-63. doi:10.1038/nri886
40. bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol (2004) 173:6418-26.
41. brightCD16- NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol (2006) 36:118-28. doi:10.1002/eji.200535243
42. brightCD16- cells and display an impaired capability to kill tumor cells. Cancer (2008) 112:863-75. doi:10.1002/cncr.23239
43. -like receptors. J Immunol (2009) 183:1789-96. doi:10.4049/jimmunol.0900541
44. Ferlazzo G, Thomas D, Pack M, Paludan C, Schmid D, Strowig T, et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A (2004) 101:16606-11. doi:10.1073/pnas.0407522101
45. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity (2007) 26:503-17. doi:10.1016/j.immuni.2007.03.006
46. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol (2004) 5:1260-5. doi:10.1038/ni1138
47. Beuneu H, Deguine J, Breart B, Mandelboim O, Di Santo JP, Bousso P. Dynamic behavior of NK cells during activation in lymph nodes. Blood (2009) 114:3227-34. doi:10.1182/blood-2009-06-228759
48. -gamma production upon interaction with dendritic cells. Eur J Immunol (2004) 34:1715-22. doi:10.1002/eji.200425100
49. Buentke E, Heffler LC, Wilson JL, Wallin RP, Lofman C, Chambers BJ, et al. Natural killer and dendritic cell contact in lesional atopic dermatitis skin-Malassezia-influenced cell interaction. J Invest Dermatol (2002) 119:850-7. doi:10.1046/j.1523-1747.2002.00132.x
50. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol (2003) 21:685-711. doi:10.1146/annurev.immunol.21.120601.141040
51. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Münz C. Human dendritic cells activate resting NK cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med (2002) 195:343-51. doi:10.1084/jem.20011149
52. Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med (2002) 195:335-41. doi:10.1084/jem.20010934
53. Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol (2003) 33:1657-66. doi:10.1002/eji.200390042
54. + self-reactive T cells. J Immunol (2008) 180:4679-86.
55. Gasteiger G, Hemmers S, Bos PD, Sun JC, Rudensky AY. IL-2-dependent adaptive control of NK cell homeostasis. J Exp Med (2013) 210:1179-87. doi:10.1084/jem.20122571
56. Gasteiger G, Hemmers S, Firth MA, Le Floc'h A, Huse M, Sun JC, et al. IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells. J Exp Med (2013) 210:1167-78. doi:10.1084/jem.20122462
57. + myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res (2005) 11:6713-21. doi:10.1158/1078-0432.CCR-05-0883
58. Elkabets M, Ribeiro VS, Dinarello CA, Ostrand-Rosenberg S, Di Santo JP, Apte RN, et al. IL-1beta regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function. Eur J Immunol (2010) 40:3347-57. doi:10.1002/eji.201041037
59. Vincent J, Mignot G, Chalmin F, Ladoire S, Bruchard M, Chevriaux A, et al. 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Res (2010) 70:3052-61. doi:10.1158/0008-5472.CAN-09-3690
60. Chaix J, Tessmer MS, Hoebe K, Fuseri N, Ryffel B, Dalod M, et al. Cutting edge: priming of NK cells by IL-18. J Immunol (2008) 181:1627-31.
61. Brilot F, Strowig T, Roberts SM, Arrey F, Münz C. NK cell survival mediated through the regulatory synapse with human dendritic cells requires IL-15Ralpha. J Clin Invest (2007) 117:3316-29. doi:10.1172/JCI31751
62. Duitman EH, Orinska Z, Bulanova E, Paus R, Bulfone-Paus S. How a cytokine is chaperoned through the secretory pathway by complexing with its own receptor: lessons from interleukin-15 (IL-15)/IL-15 receptor alpha. Mol Cell Biol (2008) 28:4851-61. doi:10.1128/MCB.02178-07
63. Gerosa F, Gobbi A, Zorzi P, Burg S, Briere F, Carra G, et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol (2005) 174:727-34.
64. Münz C, Dao T, Ferlazzo G, De Cos MA, Goodman K, Young JW. Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood (2005) 105:266-273. doi:10.1182/blood-2004-06-2492
65. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med (2002) 195:327-33. doi:10.1084/jem.20010938
66. Mocikat R, Braumuller H, Gumy A, Egeter O, Ziegler H, Reusch U, et al. Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity (2003) 19:561-9. doi:10.1016/S1074-7613(03)00264-4
67. + T-cell-independent pathway for antitumor CTL induction. Blood (2005) 106:338-44. doi:10.1182/blood-2004-09-3775
68. Laouar Y, Sutterwala FS, Gorelik L, Flavell RA. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol (2005) 6:600-7. doi:10.1038/ni1197
69. Münz C, Steinman RM, Fujii S. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med (2005) 202:203-7. doi:10.1084/jem.20050810
70. Morandi B, Bougras G, Muller WA, Ferlazzo G, Münz C. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion. Eur J Immunol (2006) 36:2394-400. doi:10.1002/eji.200636290
71. + NK helper cells. J Exp Med (2005) 202:941-53. doi:10.1084/jem.20050128
72. Wong JL, Mailliard RB, Moschos SJ, Edington H, Lotze MT, Kirkwood JM, et al. Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells. J Immunother (2011) 34:270-8. doi:10.1097/CJI.0b013e31820b370b
73. + T cells to the tumor microenvironment. Cancer Res (2013) 73:4653-62. doi:10.1158/0008-5472.CAN-12-4366
74. Vitale M, Della Chiesa M, Carlomagno S, Pende D, Arico M, Moretta L, et al. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood (2005) 106:566-71. doi:10.1182/blood-2004-10-4035
75. Pende D, Castriconi R, Romagnani P, Spaggiari GM, Marcenaro S, Dondero A, et al. Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction. Blood (2006) 107:2030-6. doi:10.1182/blood-2005-07-2696
76. Balsamo M, Zambello R, Teramo A, Pedrazzi M, Sparatore B, Scordamaglia F, et al. Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30. Exp Hematol (2009) 37:1167-75. doi:10.1016/j.exphem.2009.06.010
77. Orange JS. Formation and function of the lytic NK-cell immunological synapse. Nat Rev Immunol (2008) 8:713-25. doi:10.1038/nri2381
78. Huse M, Catherine Milanoski S, Abeyweera TP. Building tolerance by dismantling synapses: inhibitory receptor signaling in natural killer cells. Immunol Rev (2013) 251:143-53. doi:10.1111/imr.12014
79. Borg C, Abdelali J, Laderach D, Maruyama K, Wakasugi H, Charrier S, et al. NK cell activation by dendritic cells (DC) require the formation of a synapse leading to IL-12 polarization in DC. Blood (2004) 104:3267-3275. doi:10.1182/blood-2004-01-0380
80. Semino C, Angelini G, Poggi A, Rubartelli A. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood (2005) 106:609-16. doi:10.1182/blood-2004-10-3906
81. Barreira da Silva R, Graf C, Münz C. Cytoskeletal stabilization of inhibitory interactions in immunologic synapses of mature human dendritic cells with natural killer cells. Blood (2011) 118:6487-98. doi:10.1182/blood-2011-07-366328
82. Vosshenrich CA, Garcia-Ojeda ME, Samson-Villeger SI, Pasqualetto V, Enault L, Richard-Le Goff O, et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat Immunol (2006) 7:1217-24. doi:10.1038/ni1395
83. Caskey M, Lefebvre F, Filali-Mouhim A, Cameron MJ, Goulet JP, Haddad EK, et al. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J Exp Med (2011) 208:2357-66. doi:10.1084/jem.20111171
84. Strowig T, Chijioke O, Carrega P, Arrey F, Meixlsperger S, Rämer PC, et al. Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood (2010) 116:4158-67. doi:10.1182/blood-2010-02-270678
85. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (2002) 295:2097-100. doi:10.1126/science.1068440
86. Velardi A, Ruggeri L, Mancusi A. Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant. Curr Opin Hematol (2012) 19:319-23. doi:10.1097/MOH.0b013e32835423c3
87. Beilke JN, Kuhl NR, Van Kaer L, Gill RG. NK cells promote isletallograft tolerance via a perforin-dependent mechanism. Nat Med (2005) 11:1059-65. doi:10.1038/nm1296
88. Yu G, Xu X, Vu MD, Kilpatrick ED, Li XC. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med (2006) 203:1851-8. doi:10.1084/jem.20060603
89. Laffont S, Seillet C, Ortaldo J, Coudert JD, Guery JC. Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood (2008) 112:661-71. doi:10.1182/blood-2007-10-120089
90. Jungraithmayr W, Codarri L, Bouchaud G, Krieg C, Boyman O, Gyulveszi G, et al. Cytokine complex-expanded natural killer cells improve allogeneic lung transplant function via depletion of donor dendritic cells. Am J Respir Crit Care Med (2013) 187:1349-59. doi:10.1164/rccm.201209-1749OC
91. Mueller SN, Gebhardt T, Carbone FR, Heath WR. Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol (2013) 31:137-61. doi:10.1146/annurev-immunol-032712-095954